Welcome to LookChem.com Sign In|Join Free

CAS

  • or
RN-18 is a compound that acts as a selective inhibitor of the virion infectivity factor (Vif) APOBEC interactions and HIV-1 replication. It is designed to target and disrupt the interaction between Vif and APOBEC proteins, which are crucial for the replication and infectivity of the HIV-1 virus.

431980-38-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 431980-38-0 Structure
  • Basic information

    1. Product Name: RN-18
    2. Synonyms: RN-18
    3. CAS NO:431980-38-0
    4. Molecular Formula: C20H16N2O4S
    5. Molecular Weight: 380.41704
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 431980-38-0.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 493.6±40.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.36±0.1 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 12.33±0.70(Predicted)
    10. CAS DataBase Reference: RN-18(CAS DataBase Reference)
    11. NIST Chemistry Reference: RN-18(431980-38-0)
    12. EPA Substance Registry System: RN-18(431980-38-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 431980-38-0(Hazardous Substances Data)

431980-38-0 Usage

Uses

Used in Pharmaceutical Industry:
RN-18 is used as an antiviral agent for the inhibition of HIV-1 replication. By selectively targeting the Vif-APOBEC interactions, RN-18 can potentially reduce the infectivity of the virus and help in the development of new therapeutic strategies against HIV-1.
Additionally, if there are other industries where RN-18 is used, they can be listed as follows:
Used in Research and Development:
RN-18 is used as a research tool for studying the mechanisms of HIV-1 replication and the role of Vif-APOBEC interactions in the virus life cycle. This can help researchers gain a better understanding of the virus and contribute to the development of novel antiviral therapies.
Used in Drug Discovery:
RN-18 serves as a lead compound in the search for new drugs targeting HIV-1. Its selective inhibition of Vif-APOBEC interactions can be a starting point for the design and synthesis of more potent and specific inhibitors, potentially leading to the development of new anti-HIV drugs.

Check Digit Verification of cas no

The CAS Registry Mumber 431980-38-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,1,9,8 and 0 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 431980-38:
(8*4)+(7*3)+(6*1)+(5*9)+(4*8)+(3*0)+(2*3)+(1*8)=150
150 % 10 = 0
So 431980-38-0 is a valid CAS Registry Number.

431980-38-0Relevant articles and documents

Synthesis and structure-activity relationship studies of hiv-1 virion infectivity factor (vif) inhibitors that block viral replication

Ali, Akbar,Wang, Jinhua,Nathans, Robin S.,Cao, Hong,Sharova, Natalia,Stevenson, Mario,Rana, Tariq M.

, p. 1217 - 1229 (2012/07/17)

The human immunodeficiency virus1 (HIV-1) virion infectivity factor (Vif) protein, essential for in vivo viral replication, protects the virus from innate antiviral cellular factor apolipoproteinB mRNA-editing, enzyme-catalytic, polypeptide-like3G (APOBEC

SAR and lead optimization of an HIV-1 Vif-APOBEC3G axis inhibitor

Mohammed, Idrees,Parai, Maloy K.,Jiang, Xinpeng,Sharova, Natalia,Singh, Gatikrushna,Stevenson, Mario,Rana, Tariq M.

, p. 465 - 469 (2012/09/22)

We describe structure-activity relationship and optimization studies of RN-18, an HIV-1 Vif-APOBEC3G axis inhibitor. Targeted modifications of RN-18 ring C, ring B, ring A, bridge A-B, and bridge B-C were performed to identify the crucial structural features, which generated new inhibitors with similar (4g and 4i) and improved (5, 8b, and 11) activities. Two potent water-soluble RN-18 analogues, 17 and 19, are also disclosed, and we describe the results of pharmacological studies with compound 19. The findings described here will be useful in the development of more potent Vif inhibitors and in the design of probes to identify the target protein of RN-18 and its analogues.

Composition and synthesis of new reagents for inhibition of HIV replication

-

Page/Page column 26; 27, (2008/06/13)

The present invention provides compounds and compositions for inhibiting Vif and methods for treating viral infection, e.g., HIV infection.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 431980-38-0